Details for: BDP1
Gene ID: 55814
Gene Type: Protein-coding - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.
Symbol: BDP1
Ensembl ID: ENSG00000145734
Description: BDP1 general transcription factor IIIB subunit
Cell Significance Landscape
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 31.19rCSI 68.91%PRS 9.4
-
CSI 25.7rCSI 62.47%PRS 7.47
-
CSI 24.17rCSI 16.28%PRS 15.69
-
CSI 22.61rCSI 70.66%PRS 8.2
-
CSI 20.53rCSI 27.45%PRS 17.3
-
CSI 19.14rCSI 68.88%PRS 7.11
-
CSI 18.2rCSI 22.64%PRS 7.12
-
CSI 17.92rCSI 67.71%PRS 7.8
-
CSI 17.67rCSI 29.66%PRS 7.68
-
CSI 16.61rCSI 36.03%PRS 7.18
-
CSI 15.76rCSI 49.29%PRS 8.78
-
CSI 15.43rCSI 19.9%PRS 8.05
-
CSI 14.14rCSI 22.74%PRS 8.39
-
CSI 12.67rCSI 30.95%PRS 13.04
-
CSI 11.87rCSI 31.61%PRS 10.27
-
CSI 11.81rCSI 69.54%PRS 8.01
-
CSI 11.38rCSI 83.62%PRS 6.67
-
CSI 10.69rCSI 15.78%PRS 20.56
-
CSI 10.68rCSI 8.08%PRS 18.06
-
CSI 10.26rCSI 41.41%PRS 11.55
-
CSI 9.77rCSI 17.26%PRS 7.63
-
CSI 7.85rCSI 6.8%PRS 14.56
-
CSI 7.67rCSI 9.63%PRS 16.64
-
CSI 7.49rCSI 64.5%PRS 4.33
-
CSI 7.46rCSI 10.55%PRS 18.25
-
CSI 7.32rCSI 12.51%PRS 26.23
-
CSI 6.99rCSI 8.21%PRS 15.35
-
CSI 6.59rCSI 22.57%PRS 11.53
-
CSI 5.93rCSI 9.43%PRS 11.18
-
CSI 5.53rCSI 7.57%PRS 14.84
-
CSI 5.37rCSI 17.66%PRS 6.77
-
CSI 5.26rCSI 10.45%PRS 13.9
-
CSI 4.67rCSI 3.24%PRS 15.31
-
CSI 4.64rCSI 11.99%PRS 12.18
-
CSI 4.56rCSI 64.68%PRS 9.08
-
CSI 4.48rCSI 5.35%PRS 7.49
-
CSI 4.45rCSI 13.21%PRS 19.14
-
CSI 4.29rCSI 87.31%PRS 10.01
-
CSI 4.27rCSI 6.06%PRS 12.16
-
CSI 4.25rCSI 12.53%PRS 15.96
-
CSI 4.22rCSI 85.83%PRS 10.95
-
CSI 4.18rCSI 36.1%PRS 23.04
-
CSI 3.94rCSI 62.16%PRS 6.86
-
CSI 3.8rCSI 10.14%PRS 11.05
-
CSI 3.7rCSI 88.65%PRS 5.91
-
CSI 3.65rCSI 88.18%PRS 6.79
-
CSI 3.37rCSI 5.17%PRS 15.25
-
CSI 3.37rCSI 8.77%PRS 11.94
-
CSI 3.08rCSI 15.88%PRS 25.67
-
CSI 3.04rCSI 2.64%PRS 16.12
-
CSI 2.92rCSI 9.01%PRS 20.12
-
CSI 2.91rCSI 6.97%PRS 7.18
-
CSI 2.74rCSI 2.04%PRS 21.93
-
CSI 2.67rCSI 14.02%PRS 23.06
-
CSI 2.67rCSI 28.23%PRS 18.03
-
CSI 2.58rCSI 2.07%PRS 23.67
-
CSI 2.4rCSI 9.6%PRS 28.54
-
CSI 2.35rCSI 1.76%PRS 21.15
-
CSI 2.33rCSI 16.67%PRS 28.63
-
CSI 2.28rCSI 1.59%PRS 13.7
-
CSI 2.23rCSI 5.78%PRS 17.25
-
CSI 2.2rCSI 3.05%PRS 18.75
-
CSI 2.19rCSI 1.88%PRS 22.9
-
CSI 2.19rCSI 3.41%PRS 31.31
-
CSI 2.07rCSI 4.94%PRS 20.27
-
CSI 2.05rCSI 11.06%PRS 24.44
-
CSI 2.03rCSI 8.93%PRS 24.34
-
CSI 2.03rCSI 7.91%PRS 21.41
-
CSI 1.93rCSI 2.17%PRS 20.92
-
CSI 1.88rCSI 6.69%PRS 40.48
-
CSI 1.83rCSI 1.08%PRS 18
-
CSI 1.82rCSI 1.68%PRS 13.26
-
CSI 1.82rCSI 2.33%PRS 15.08
-
CSI 1.81rCSI 1.5%PRS 13.07
-
CSI 1.81rCSI 4.48%PRS 12.06
-
CSI 1.76rCSI 11.28%PRS 19.62
-
CSI 1.74rCSI 2.68%PRS 18.55
-
CSI 1.67rCSI 6.27%PRS 11.07
-
CSI 1.6rCSI 3.76%PRS 19.7
-
CSI 1.59rCSI 1.87%PRS 17.33
-
CSI 1.59rCSI 2.62%PRS 15.2
-
CSI 1.59rCSI 3.62%PRS 11.43
-
CSI 1.58rCSI 2.26%PRS 14.72
-
CSI 1.52rCSI 1.2%PRS 15.52
-
CSI 1.52rCSI 4.39%PRS 14.82
-
CSI 1.51rCSI 1.01%PRS 33.85
-
CSI 1.5rCSI 3.43%PRS 12.6
-
CSI 1.49rCSI 2.58%PRS 9.95
-
CSI 1.49rCSI 3.28%PRS 20.03
-
CSI 1.45rCSI 7.12%PRS 17.74
-
CSI 1.43rCSI 5.68%PRS 18.37
-
CSI 1.42rCSI 2.91%PRS 13.3
-
CSI 1.41rCSI 1.06%PRS 13.55
-
CSI 1.4rCSI 1.38%PRS 48.46
-
CSI 1.38rCSI 1.35%PRS 20.52
-
CSI 1.37rCSI 1.5%PRS 14.95
-
CSI 1.37rCSI 1.02%PRS 19.35
-
CSI 1.34rCSI 1.79%PRS 51.48
-
CSI 1.33rCSI 1.29%PRS 9.03
-
CSI 1.32rCSI 1.16%PRS 14.67
-
CSI -4.1rCSI -11.6%PRS 18.6%
-
CSI -2.8rCSI -4.4%PRS 12.2%
-
CSI -2.3rCSI -2.9%PRS 13.0%
-
CSI -1.9rCSI -1.7%PRS 13.1%
-
CSI -1.2rCSI -12.6%PRS 23.6%
-
CSI -0.9rCSI -1.4%PRS 19.2%
-
CSI -0.6rCSI -9.5%PRS 48.9%
-
CSI -0.4rCSI -1.7%PRS 23.4%
-
CSI -0.3rCSI -1.4%PRS 33.3%
-
CSI -0.2rCSI -0.2%PRS 14.0%
-
CSI -0.2rCSI -0.2%PRS 14.3%
-
CSI -0.1rCSI -1.4%PRS 12.3%
-
CSI -0.1rCSI -0.1%PRS 9.6%
-
CSI 0.0rCSI -0.1%PRS 21.5%
-
CSI 0.0rCSI 0.1%PRS 12.2%
-
CSI 0.1rCSI 0.3%PRS 19.1%
-
CSI 0.1rCSI 1.4%PRS 55.1%
-
CSI 0.1rCSI 0.2%PRS 21.9%
-
CSI 0.1rCSI 0.1%PRS 21.2%
-
CSI 0.1rCSI 0.7%PRS 5.4%
-
CSI 0.1rCSI 1.7%PRS 40.4%
-
CSI 0.1rCSI 0.2%PRS 18.3%
-
CSI 0.1rCSI 0.5%PRS 20.1%
-
CSI 0.1rCSI 2.8%PRS 30.0%
-
CSI 0.1rCSI 0.5%PRS 30.9%
-
CSI 0.1rCSI 0.1%PRS 9.5%
-
CSI 0.1rCSI 0.4%PRS 21.4%
-
CSI 0.1rCSI 0.5%PRS 25.0%
-
CSI 0.1rCSI 0.1%PRS 11.6%
-
CSI 0.1rCSI 0.8%PRS 35.1%
-
CSI 0.1rCSI 0.3%PRS 19.6%
-
CSI 0.1rCSI 0.5%PRS 13.9%
-
CSI 0.2rCSI 1.0%PRS 25.5%
-
CSI 0.2rCSI 0.5%PRS 10.1%
-
CSI 0.2rCSI 0.3%PRS 13.8%
-
CSI 0.2rCSI 1.0%PRS 19.6%
-
CSI 0.2rCSI 0.5%PRS 13.3%
-
CSI 0.2rCSI 0.4%PRS 16.2%
-
CSI 0.2rCSI 0.8%PRS 13.5%
-
CSI 0.2rCSI 0.2%PRS 22.4%
-
CSI 0.2rCSI 0.9%PRS 5.2%
-
CSI 0.2rCSI 0.3%PRS 24.9%
-
CSI 0.2rCSI 2.4%PRS 49.1%
-
CSI 0.2rCSI 1.0%PRS 26.9%
-
CSI 0.2rCSI 0.3%PRS 15.0%
-
CSI 0.2rCSI 2.6%PRS 32.5%
-
CSI 0.2rCSI 0.4%PRS 28.3%
-
CSI 0.2rCSI 0.3%PRS 21.0%
-
CSI 0.2rCSI 2.6%PRS 25.1%
-
CSI 0.2rCSI 1.1%PRS 12.7%
-
CSI 0.2rCSI 0.6%PRS 16.5%
-
CSI 0.3rCSI 1.6%PRS 13.2%
-
CSI 0.3rCSI 0.3%PRS 20.0%
-
CSI 0.3rCSI 0.5%PRS 20.0%
-
CSI 0.3rCSI 1.4%PRS 43.5%
-
CSI 0.3rCSI 2.1%PRS 28.2%
-
CSI 0.3rCSI 1.4%PRS 17.1%
-
CSI 0.3rCSI 4.2%PRS 32.3%
-
CSI 0.3rCSI 0.4%PRS 12.9%
-
CSI 0.3rCSI 1.8%PRS 33.7%
-
CSI 0.3rCSI 1.1%PRS 2.6%
-
CSI 0.3rCSI 0.2%PRS 13.8%
-
CSI 0.3rCSI 0.6%PRS 21.0%
-
CSI 0.3rCSI 0.6%PRS 33.7%
-
CSI 0.3rCSI 1.8%PRS 29.0%
-
CSI 0.3rCSI 0.8%PRS 16.2%
-
CSI 0.3rCSI 0.6%PRS 13.3%
-
CSI 0.3rCSI 0.4%PRS 13.3%
-
CSI 0.3rCSI 7.7%PRS 71.8%
-
CSI 0.3rCSI 1.0%PRS 10.1%
-
CSI 0.3rCSI 0.5%PRS 11.7%
-
CSI 0.4rCSI 0.4%PRS 12.9%
-
CSI 0.4rCSI 0.6%PRS 17.5%
-
CSI 0.4rCSI 0.4%PRS 15.4%
-
CSI 0.4rCSI 0.6%PRS 12.9%
-
CSI 0.4rCSI 2.1%PRS 5.4%
-
CSI 0.4rCSI 0.7%PRS 17.3%
-
CSI 0.4rCSI 0.8%PRS 22.5%
-
CSI 0.4rCSI 1.4%PRS 9.0%
-
CSI 0.4rCSI 1.5%PRS 13.3%
-
CSI 0.4rCSI 3.9%PRS 52.3%
-
CSI 0.4rCSI 1.0%PRS 23.7%
-
CSI 0.4rCSI 0.4%PRS 12.2%
-
CSI 0.4rCSI 2.4%PRS 45.3%
-
CSI 0.4rCSI 0.9%PRS 26.4%
-
CSI 0.4rCSI 0.6%PRS 31.3%
-
CSI 0.4rCSI 1.0%PRS 18.2%
-
CSI 0.4rCSI 0.5%PRS 17.3%
-
CSI 0.4rCSI 2.2%PRS 15.0%
-
CSI 0.4rCSI 2.1%PRS 8.7%
-
CSI 0.4rCSI 0.6%PRS 11.9%
-
CSI 0.4rCSI 1.9%PRS 9.7%
-
CSI 0.4rCSI 0.8%PRS 35.4%
-
CSI 0.5rCSI 0.7%PRS 17.1%
-
CSI 0.5rCSI 1.3%PRS 20.2%
-
CSI 0.5rCSI 2.3%PRS 14.1%
-
CSI 0.5rCSI 1.5%PRS 19.1%
-
CSI 0.5rCSI 2.4%PRS 23.5%
-
CSI 0.5rCSI 1.5%PRS 15.7%
-
CSI 0.5rCSI 0.9%PRS 9.5%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 1957741077
Symbol: BDP1_HUMAN
Name: Transcription factor TFIIIB component B'' homolog
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 11040218
Title: Different human TFIIIB activities direct RNA polymerase III transcription from TATA-containing and TATA-less promoters.
PubMed ID: 11040218
DOI: 10.1101/gad.836400
PubMed ID: 11161782
Title: The transcription factor-like nuclear regulator (TFNR) contains a novel 55-amino-acid motif repeated nine times and maps closely to SMN1.
PubMed ID: 11161782
PubMed ID: 10574462
Title: Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.
PubMed ID: 10574462
PubMed ID: 11214970
Title: Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.
PubMed ID: 11214970
PubMed ID: 12168954
Title: Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.
PubMed ID: 12168954
PubMed ID: 17974005
Title: The full-ORF clone resource of the German cDNA consortium.
PubMed ID: 17974005
PubMed ID: 15372022
Title: The DNA sequence and comparative analysis of human chromosome 5.
PubMed ID: 15372022
DOI: 10.1038/nature02919
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
PubMed ID: 11121026
Title: A stable complex of a novel transcription factor IIB- related factor, human TFIIIB50, and associated proteins mediate selective transcription by RNA polymerase III of genes with upstream promoter elements.
PubMed ID: 11121026
PubMed ID: 14592981
Title: TFIIIB is phosphorylated, disrupted and selectively released from tRNA promoters during mitosis in vivo.
PubMed ID: 14592981
DOI: 10.1093/emboj/cdg544
PubMed ID: 15096501
Title: Transcription factor (TF)-like nuclear regulator, the 250-kDa form of Homo sapiens TFIIIB', is an essential component of human TFIIIC1 activity.
PubMed ID: 15096501
PubMed ID: 15469824
Title: CK2 phosphorylation of Bdp1 executes cell cycle-specific RNA polymerase III transcription repression.
PubMed ID: 15469824
PubMed ID: 16542149
Title: The zinc finger protein ZNF297B interacts with BDP1, a subunit of TFIIIB.
PubMed ID: 16542149
DOI: 10.1515/bc.2006.037
PubMed ID: 16769183
Title: A role for Yin Yang-1 (YY1) in the assembly of snRNA transcription complexes.
PubMed ID: 16769183
PubMed ID: 16956891
Title: Epstein-Barr virus induces cellular transcription factors to allow active expression of EBER genes by RNA polymerase III.
PubMed ID: 16956891
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 24312468
Title: Linkage study and exome sequencing identify a BDP1 mutation associated with hereditary hearing loss.
PubMed ID: 24312468
Sequence Information:
- Length: 2624
- Mass: 293885
- Checksum: CB7B80EBBF06B557
- Sequence:
MFRRARLSVK PNVRPGVGAR GSTASNPQRG RESPRPPDPA TDSASKPAEP TDVPTVDFGG AEPQEKAPRS STEKTGGDND VEESSRSSST VSQRRKRISS TSSLVKSSVS VPSESHPLST INQEAPQPTA TSTKEKQPCS DRYRIYKAQK LREMLKEELR KEKKQWKNKY AINESQRPPD RSKMTMRDFI YYLPDNNPMT SSLEQEKKTE KPSTPVQTRE QEGKSTPNAE DNEMEEETDD GPLLVPRVKV AEDGSIILDE ESLTVEVLRT KGPCVVEEND PIFERGSTTT YSSFRKNYYS KPWSNKETDM FFLAISMVGT DFSMIGQLFP HRARIEIKNK FKREEKTNGW RIDKAFQEKR PFDFDFFAHL LQKVLAEEEK RKQKSVKNHS LKEKKSTKPR KNVKVKKVAC EGVNNDPDES MSSRISDTER SQKDAQTVEE ESLTLSREDA EQVALEVDLN QKKRRRKKQD GANELGVNNL LENATVQAGP SKGEKHKNKC QAIRPELKEG ECSKEQMLSC TQNIDGIVGF ASTEKVEKRT DPILSLSNQQ DATSVATESS ESSTSDLPSF EVGIRALCEV NNAEGSCIEE RNVDLKNNSL EIDQTENVKP MLRGRFQRPK PNLSRAGKKS VLSQGKTESE SKNSHSKTSV EKNHVEKDKM NTLDILRMET TERENPEAET VSVLGEKNCL QEGSQLKALR PVQVRGRLQK PKPNAGKAAE RKEILISQEE IGANVEKNEN ESCADRDTPQ HMEDQSRKDF EEEDVILQPE KNDSFQNVQP DEPKVLNECL SVQENNKANK LNQVPILRTR FQKPKPNIGR GTGRREISSK EEVLEKILVS GEMAAALRET VRLDTSPKEM VPAEINTKEM QSDLKETGRR AISPREKILD VIDDTIEMET GLKAMGREIC LREKTPEVID ATEEIDKDLE EAGRREISPQ KNGPEEVKPL GEVETDLKAT GNESSPREKT PEVTDATEEI DKNLEETGRR KISPRENGPE EVKPVDEMET DLNATGRESS PREKTPEVID ATEEIDLEET EREVSPQENG LEEVKPLGEM ETDLKATGRD SFPRGKTPEV IDAIEEIEID LEETEREISP QENGLEEVKP LGEMQTDLKA TGREISPREK TPEVIDATEE IDKDLEETGR REISPEENGP EEVKPVDEME TDLKTTGREG SSREKTREVI DAAEVIETDL EETEREISPQ ENGPEEVKPV GKMETDLKEI REEISQREKV LAEFSAIREK EIDLKETGKR DIPIMEKVSG KMAVVEEMEA DLKETGKENF RERGSEEICV TEEKVAELKQ TGKTDISPRE NELEETSTSR QTDTHLMQSG SNDFSAVPSL DIQNISSEVL SMMHTPVEEK RNSEKEVSSH FSHFKISSQT HESDKTEVQG IQSPDVPEQF SDINLSKSLP QEQKPLEIKP APFVRSRFKR PKPNLARAAL KRETTESEKY IYEKKSETKK METIVMQENN EQTDTLPSQH DEASLMISRE KDTLGHRNEE AVILPCTQTE RNLSPSNSCE PKEESQSAPV QKNDSVVSVG TNNVNTFQQE MKESVIQTAR QVRGRLQRPR PNIRKTGQRQ IVDKGEAKGI IKEGRTILPK DETEKKVLTV SNSQIETEIE VPSSAVPEHR MYENQSQVVL VENLHVNKTN ETIRHENKPY VPSSAQMTRR KFQKAKPNLG RAHSKKEEPV LEKVTTDQSK EGKPEDHLLQ KGASNTQLLL KEKAELLTSL EVSARKDCVG SKESALAKID AELEEVGPSR RVGEETVGDN SPSSVVEEQY LNKLTSCPQP LNETSYSKIA LDGKTTISST SEYERNRGER RSHKKFKPNV TRGRGSKRVR GKTSKKEPRA SKAMLVTLRA SQEEDDDADD FESDYEEESY HLAPEEVNKA PVFVPVGLRS PEPVSAQIEE TMEELEITVN VPDVGCIAVV EHELPNTDVT TEEMKQEENL SVPFEMTTSE HIQDEPGTND GSTEAAITLL TMGDLVLQSE ISSEQGDVGV CIIPHVHSKD KSHIPSSLDN VNHKIVHECQ ELSSPVITTS PASFEENKIV LEEQSSREEI SLMEKVKENA TPTRNTISKV TSNLRIRSRL AKPKPNLEKT LGTNRLDDYQ EVSSLCVTKG AEMETQRETE KNASKATELE NKNLGPVTTA ENKDQSKLAC VHGIKGTSIS SEVNLTERNE NQEESSQEVH MLSVAPVASS ETGPCTLGLD RGLGENSVEE PQIKDSKGDS VLTLPVPEYT PTSIPEVQQE NIINPQDLTV NLVANVPQDG EDEQAFILTL VEIPANAVEE FTDATAQFMP NPLLPAPILV KSVNTEERGD MSICLPATSV GQDAMGLSIS GRDNSKKPPD NLDLVSRKRF QCRLDKNDHI PPAKKRSLTL RDDCQEYTTE VHSKELTNVF EETGESHKGQ DIFLTSGSTL TTPEPQRQQV EAAFQSRGSR SPDACMDKNV PQLPQDEMIV SDKEERTDAA PKSQQMDSRT SSSKASLSRP GRRPLGFLSL ICSKNSLESD EPMQVHSKKR LKPLIPGLRK KLKRSNPFNE SQEKNRESSD LLPSPSVITT QSENISSSAT QVSCDQPLLK EGYKSAQKRA PQGEATTVSE YFFNDIFIEV DETE